Nurse Practitioners (NPs) and Physician Assistants (PAs) are no longer just “support” staff for physicians. These clinicians are now taking on much bigger roles in patient care, including the ability to prescribe medications without physician oversight.  The COVID-19 pandemic accelerated the already growing trend of expanding NPs’ and PAs’ scope of practice. Now, five years…

The digital advertising landscape is shifting rapidly, and for healthcare and pharmaceutical marketers, the stakes are higher than ever. With evolving privacy regulations, increasing scrutiny on data practices and the challenge of balancing precision targeting with consumer protection, advertisers must rethink their strategies to stay effective and compliant. To tackle these pressing issues, PurpleLab recently…

The Give Kids a Chance Act of 2025 is a piece of legislation poised to transform drug development for children with rare diseases and cancer. Reintroduced in the House of Representatives on February 12, 2025, by Congressman Michael McCaul, this bipartisan effort aims to extend the Priority Review Voucher (PRV) program beyond its anticipated September…

If you’re following along at all with the TikTok news, you’ll know that the app faced a temporary ban in the US followed by a quick reversal – for now. The platform has become a global smash hit since it lets users post short-form videos with ease, along with seamless app navigation enabling them to instantly view and interact with videos they may be interested in.

A healthcare media agency wanted to increase awareness of their brand with additional direct to consumer (DTC), HIPAA and NAI compliant, privacy safe audiences. They wanted to drive prescriptions for consumers with migraines. The audiences needed to be applicable across channels and activatable on their preferred demand side platform (DSP).

Launching a new pharmaceutical product is a high-stakes endeavor, with nearly 40% of launches failing to meet expectations. To improve these odds, companies must shift to a data-driven approach, leveraging real-world insights to engage decision-makers effectively across the patient journey.

Authored by Lauren Kushner, Head of Healthcare at MiQ, and Ted Sweetser, VP of Advertising Partnerships and Strategy at PurpleLab. 2024 was a year of considerable change for the pharmaceutical industry. The biggest trend was undoubtedly the progression of the Inflation Reduction Act’s negotiated drug pricing, which sees CMS negotiating on pricing for a published…

Learn more about what PurpleLab can do for Clinical Trials Life Sciences Clinical trials are essential for drug development, yet they frequently face delays due to ineffective site selection, leading to protocol violations, compromised data quality, and soaring costs. In fact, 90% of trials fail to meet their timelines, often due to inadequate staffing and…

This article highlights some of the key takeaways of a webinar sponsored by Datavant. The webinar included a panel of representatives from leading companies in pharmaceutical marketing and technology, each bringing unique perspectives on marketing trends, data, compliance, activation and strategy: Scott Ronay, Partnerships, Datavant Joe Kotz, SVP Product Sales, VideoAmp Ted Sweetser VP of…